Research Scientist
University of California-Irvine Medical Center
Dr. Sangjun Lee is a Clinical Laboratory Scientist (CGMBS/ASCP-MB) with a Ph.D. in Cancer Biology and over ten years of experience in cancer genetics, NGS panel development, and molecular diagnostics. His expertise includes assay validation, variant detection, bioinformatics analysis, and clinical reporting for precision oncology.
He trained at the University of Texas MD Anderson Cancer Center, where he investigated oncogenic signaling pathways and published on Ras and Bcl-2 in cancer biology. In the clinical setting, he has developed and validated NGS assays for hematologic malignancies and solid tumors, with experience spanning qPCR, Sanger sequencing, capillary electrophoresis, and spatial transcriptomics.
For the past two years, Dr. Lee has collaborated with Nabsys to evaluate electronic genome mapping (EGM) for structural variant detection in leukemia. This work demonstrated high-resolution identification of TP53 deletions and clinically significant fusions, establishing EGM as a promising complement to traditional cytogenetic and sequencing methods in diagnostic workflows.
Dr. Lee’s career bridges translational research and clinical diagnostics, with a strong commitment to advancing precision oncology through innovative genomic technologies.